Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Spectrum and characterization of bi-allelic variants in MMAB causing cblB-type methylmalonic aciduria

    Pathogenic variants in MMAB cause cblB-type methylmalonic aciduria, an autosomal-recessive disorder of propionate metabolism. MMAB encodes ATP:cobalamin adenosyltransferase, using ATP and cob(I)alamin to create 5...

    Patrick Forny, Tanja Plessl, Caroline Frei, Celine Bürer, D. Sean Froese in Human Genetics (2022)

  2. Article

    Open Access

    Epimutations in both the TESK2 and MMACHC promoters in the Epi-cblC inherited disorder of intracellular metabolism of vitamin B12

    epi-cblC is a recently discovered inherited disorder of intracellular vitamin B12 metabolism associating hematological, neurological, and cardiometabolic outcomes. It is produced by an epimutation at the promoter...

    Abderrahim Oussalah, Youssef Siblini, Sébastien Hergalant in Clinical Epigenetics (2022)

  3. Article

    Open Access

    Key patient-reported outcomes in children and adolescents with intoxication-type inborn errors of metabolism: an international Delphi-based consensus

    Acute intoxication-type inborn errors of metabolism (IT-IEM) such as urea cycle disorders and non-acute IT-IEM such as phenylketonuria (PKU) and their treatment have a major impact on the life of affected chil...

    Florin Bösch, Nina A. Zeltner, Matthias R. Baumgartner in Orphanet Journal of Rare Diseases (2022)

  4. No Access

    Chapter

    Biotin-Responsive Disorders

    Two inherited defects affecting the coenzyme function of biotin are known: holocarboxylase synthetase (HCS) deficiency and biotinidase deficiency. Both lead to deficiency of all biotin-dependent carboxylases, ...

    D. Sean Froese, Matthias R. Baumgartner in Inborn Metabolic Diseases (2022)

  5. No Access

    Book

  6. No Access

    Chapter

    Disorders of Cobalamin Metabolism

    Vitamin B12 (Cbl) is needed for just two metabolic reactions in man, the methylation of homocysteine to methionine (cofactor methyl-Cbl) and the conversion of methylmalonyl-CoA to succinyl-CoA (cofactor adenosyl-...

    Matthias R. Baumgartner, D. Sean Froese in Physician's Guide to the Diagnosis, Treatm… (2022)

  7. No Access

    Chapter

    Disorders of Ornithine and Proline Metabolism

    Hyperornithinaemia due to ornithine aminotransferase (OAT) deficiency results from loss of function mutations in OAT and causes gyrate atrophy of the choroid and retina (GA), a progressive retinal degeneration. T...

    Matthias R. Baumgartner, David Valle, Carlo Dionisi-Vici in Inborn Metabolic Diseases (2022)

  8. Article

    Open Access

    A systematic review of moral reasons on orphan drug reimbursement

    The number of market approvals of orphan medicinal products (OMPs) has been increasing steadily in the last 3 decades. While OMPs can offer a unique chance for patients suffering from rare diseases, they are u...

    Bettina M. Zimmermann, Johanna Eichinger in Orphanet Journal of Rare Diseases (2021)

  9. Article

    Open Access

    Reducing complexity: explaining inborn errors of metabolism and their treatment to children and adolescents

    Inborn errors of metabolism (IEM) are a group of rare, heterogeneous and complex genetic conditions. Clinically, IEM often affect the central nervous system and other organs. Some carry the risk of progression...

    Nina A. Zeltner, Mendy M. Welsink-Karssies in Orphanet Journal of Rare Diseases (2019)

  10. No Access

    Article

    Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: data from the E-HOD registry

    To explore the clinical presentation, course, treatment and impact of early treatment in patients with remethylation disorders from the European Network and Registry for Homocystinurias and Methylation Defects...

    Martina Huemer, Daria Diodato, Diego Martinelli in Journal of Inherited Metabolic Disease (2018)

  11. No Access

    Article

    Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders—a successful strategy for clinical research of rare diseases

    To improve our understanding of urea cycle disorders (UCDs) prospectively followed by two North American (NA) and European (EU) patient cohorts.

    Roland Posset, Sven F. Garbade, Nikolas Boy in Journal of Inherited Metabolic Disease (2018)

  12. Article

    Correction to: Impact of age at onset and newborn screening on outcome in organic acidurias

    Due to an unfortunate error during the typesetting process, the collaborators were presented incorrectly.

    Jana Heringer, Vassili Valayannopoulos in Journal of Inherited Metabolic Disease (2018)

  13. No Access

    Article

    Functional characterization of missense mutations in severe methylenetetrahydrofolate reductase deficiency using a human expression system

    5,10-Methylenetetrahydrofolate reductase (MTHFR) catalyzes the NADPH-dependent reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate using FAD as the cofactor. Severe MTHFR deficiency is the ...

    Patricie Burda, Terttu Suormala in Journal of Inherited Metabolic Disease (2017)

  14. No Access

    Chapter

    Living with Intoxication-Type Inborn Errors of Metabolism: A Qualitative Analysis of Interviews with Paediatric Patients and Their Parents

    Introduction: Progress in diagnosis and treatment of patients with intoxication-type inborn errors of metabolism (IT-IEM) such as urea cycle disorders, organic acidurias or maple syrup urine disease is resulting...

    Nina A. Zeltner, Markus A. Landolt, Matthias R. Baumgartner in JIMD Reports, Volume 31 (2017)

  15. No Access

    Chapter

    Development and Psychometric Evaluation of the MetabQoL 1.0: A Quality of Life Questionnaire for Paediatric Patients with Intoxication-Type Inborn Errors of Metabolism

    Introduction: This study is part of the “European network and registry for intoxication type metabolic diseases” (E-IMD) project. Intoxication-type inborn errors of metabolism (IT-IEM) such as urea cycle...

    Nina A. Zeltner, Matthias R. Baumgartner, Aljona Bondarenko in JIMD Reports, Volume 37 (2017)

  16. Article

    Open Access

    Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency

    Remethylation defects are rare inherited disorders in which impaired remethylation of homocysteine to methionine leads to accumulation of homocysteine and perturbation of numerous methylation reactions.

    Martina Huemer, Daria Diodato, Bernd Schwahn in Journal of Inherited Metabolic Disease (2017)

  17. Article

    Recommendations and guidelines in the JIMD: suggested procedures and avoidance of conflicts of interest

    Johannes Zschocke, Matthias R. Baumgartner in Journal of Inherited Metabolic Disease (2016)

  18. No Access

    Article

    Impact of age at onset and newborn screening on outcome in organic acidurias

    To describe current diagnostic and therapeutic strategies in organic acidurias (OADs) and to evaluate their impact on the disease course allowing harmonisation.

    Jana Heringer, Vassili Valayannopoulos in Journal of Inherited Metabolic Disease (2016)

  19. No Access

    Article

    Behavioural and emotional problems, intellectual impairment and health-related quality of life in patients with organic acidurias and urea cycle disorders

    Organic acidurias (OADs) and urea cycle disorders (UCDs) are inborn metabolic disorders with a risk for acute and chronic metabolic decompensation resulting in impairments of the central nervous system and oth...

    Dagmar Jamiolkowski, Stefan Kölker in Journal of Inherited Metabolic Disease (2016)

  20. Article

    Open Access

    Position statement on the role of healthcare professionals, patient organizations and industry in European Reference Networks

    A call from the EU for the set-up of European Reference Networks (ERNs) is expected to be launched in the first quarter of 2016. ERNs are intended to improve the care for patients with low prevalent or rare di...

    Carla E. M. Hollak, Marieke Biegstraaten in Orphanet Journal of Rare Diseases (2016)

previous disabled Page of 3